Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-04-028435
Filing Date
2004-05-27
Accepted
2004-05-27 18:39:17
Documents
2
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bob50698ps.html 3  
1 MAIN DOCUMENT DESCRIPTION bob50698ps.xml 3 5522
2 POWER OF ATTORNEY ps-poa.txt EX-24 4561
  Complete submission text file 0001209191-04-028435.txt   12092
Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142
Business Address BIOGEN INC LEGAL DEPARTMENT 14 CAMBRIDGE CENTER CAMBRIDGE MA 02142 6176792000
SHARP PHILIP A (Reporting) CIK: 0001226295 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 04836238